We have located links that may give you full text access.
Association between age, uptake of 18 F-fluorodeoxyglucose and of 18 F-sodium fluoride, as cardiovascular risk factors in the abdominal aorta.
Hellenic Journal of Nuclear Medicine 2019 January
OBJECTIVE: We aimed to assess the feasibility of quantifying fluorine-18-fluorodexoglucose (18 F-FDG) and 18 F-sodium fluoride (18 F-NaF) uptake in abdominal aorta and examine their association with age and cardiovascular risk factors.
SUBJECTS AND METHODS: Our study comprised 123 subjects (48±14 years of age, 62 men) including 78 healthy volunteers and 45 patients with chest pain syndrome, who originally enrolled in the CAMONA study in Odense, Denmark (NCT01724749). All subjects underwent 18 F-FDG positron emission tomography/computed tomography (PET/CT) and 18 F-NaF PET/CT on separate days, 180min and 90min after administration of tracers, respectively. The global tracer uptake value (GTUV) in the abdominal aorta was determined as sum of the product of each slice area and its corresponding average standardized uptake value (SUV mean), divided by the sum of those slice areas. In addition, for each subject, the 10 years Framingham risk score (FRS) was calculated. The correlations between 18 F-NaF and 18 F-FDG GTUV with age and 10 years FRS were assessed in all, healthy and patient subjects.
RESULTS: There was a significant, positive correlation between subjects' age and 18 F-NaF GTUV (r=0.35, P<0.001), but not 18 F-FDG GTUV (r=0.06, P=0.53). Also, there was a significant, positive correlation between 10 years FRS and 18 F-NaF GTUV (r=0.30, P<0.001), but not 18 F-FDG GTUV (r=0.01, P=0.95). Individual differences in 18 F-FDG and 118 F-NaF uptake were large in both healthy subjects and patients.
CONCLUSION: In this study, the global uptake of 18 F-NaF in abdominal aorta was positively associated with age and 10 years FRS in all subjects, healthy and patient groups, whereas the global uptake of 18 F-FDG was not.
SUBJECTS AND METHODS: Our study comprised 123 subjects (48±14 years of age, 62 men) including 78 healthy volunteers and 45 patients with chest pain syndrome, who originally enrolled in the CAMONA study in Odense, Denmark (NCT01724749). All subjects underwent 18 F-FDG positron emission tomography/computed tomography (PET/CT) and 18 F-NaF PET/CT on separate days, 180min and 90min after administration of tracers, respectively. The global tracer uptake value (GTUV) in the abdominal aorta was determined as sum of the product of each slice area and its corresponding average standardized uptake value (SUV mean), divided by the sum of those slice areas. In addition, for each subject, the 10 years Framingham risk score (FRS) was calculated. The correlations between 18 F-NaF and 18 F-FDG GTUV with age and 10 years FRS were assessed in all, healthy and patient subjects.
RESULTS: There was a significant, positive correlation between subjects' age and 18 F-NaF GTUV (r=0.35, P<0.001), but not 18 F-FDG GTUV (r=0.06, P=0.53). Also, there was a significant, positive correlation between 10 years FRS and 18 F-NaF GTUV (r=0.30, P<0.001), but not 18 F-FDG GTUV (r=0.01, P=0.95). Individual differences in 18 F-FDG and 118 F-NaF uptake were large in both healthy subjects and patients.
CONCLUSION: In this study, the global uptake of 18 F-NaF in abdominal aorta was positively associated with age and 10 years FRS in all subjects, healthy and patient groups, whereas the global uptake of 18 F-FDG was not.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app